TrialAtherosclerosis2016
Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.
Fumiyoshi Tsunoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it
TrialAtherosclerosis2016
Fumiyoshi Tsunoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.